Delivery Order SPE2DR25D1201-SPE2DR26FAKLM
- Not listed
- On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $3,158.20 to Amerisourcebergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units). The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. Performance will be executed from the awardee's location in Conshohocken, Pennsylvania, with completion scheduled for January 14, 2026. Amerisourcebergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order valued at $6,274.13 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on January 8, 2026, with an ultimate completion date of January 9, 2026. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award on a full and open basis. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Jardiance 10 mg tablets (90-count packages) under a firm fixed-price contract valued at $22,046.39, with completion scheduled for January 6, 2026. This non-set-aside award represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $9,798.71. This competitive, non-set-aside award is structured as a firm fixed price delivery order with an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,464.31 on January 6, 2026, for the supply of Jardiance 25 mg tablets (90-count packages). This non-set-aside, competitively awarded contract with firm fixed pricing is funded by the Defense Logistics Agency (DLA) and is scheduled for completion by January 7, 2026. The award represents a task order issued under AmerisourceBergen's parent company,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Jardiance 10 mg tablets in a quantity of 90 units, with a ceiling value of $5,100.30. This firm fixed-price delivery order, with an ultimate completion date of December 23, 2025, represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The award was made on a competitive, non-set-aside basis and will be...
- The Defense Logistics Agency awarded a delivery order valued at $7,176.95 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's corporate headquarters in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on December 22, 2025, by the Defense Logistics Agency for the supply of Jardiance 10 mg tablets (90-count packages). This non-set-aside, competitively awarded delivery order carries a firm fixed price ceiling value of $23,196.13 and is scheduled for ultimate completion on December 23, 2025. The award represents a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) valued at $7,269.84 with firm fixed pricing. This non-set-aside delivery order is scheduled for completion by December 31, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,899.94 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on December 16, 2025, with completion scheduled for December 17, 2025. The award was competitively procured under a firm fixed-price contract structure with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FAKLMDelivery Order
On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $37,240.24 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages). This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 14, 2026, with performance based in Conshohocken, Pennsylvania. The award represents a task order executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling delivery of a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies critical medications including specialty drugs, brand-name and generic pharmaceuticals, and medical commodities across multiple therapeutic domains to federal agencies. Jardiance, a diabetes management medication, represents one of many pharmaceutical products the company delivers through its federal contract portfolio. The delivery order demonstrates the company's ongoing capability to fulfill essential medical supply requirements for the Defense Logistics Agency's military healthcare operations on a competitive basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.2k | 1/12/26 |